Background
The drive to address the psychosocial issues of cancer survivors initially stemmed from Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs, which emphasized the importance of screening patients for distress as a critical first step to providing high-quality cancer care (Institute of Medicine, 2007) . The American College of Surgeons (2015) Commission on Cancer and NCCN (2016) concur that comprehensive cancer centers should develop referral programs to screen and manage distress at pivotal visits.
Distress has overwhelming consequences for cancer survivors. The true incidence of distress in gynecologic cancer survivors is difficult to know because of lack of provider inquiry, perceived negative stigma of distress, shorter clinic visits with providers, and patients' reluctance to initiate conversations because of cultural or perceived barriers (Vitek, Rosenzweig, & Stollings, 2007) . Cancer survivors face challenges with obtaining timely follow-up appointments, managing treatment side effects that limit the ability to work and perform daily activities, gaining access to care, and incurring increased medical care costs that persist throughout the survivorship period (Ekwueme et al., 2014; Urbaneic, Collins, Denson, & Whitford, 2014) . About 40%-50% of survivors experience psychosocial distress at some point during their cancer treatment and surveillance (Mitchell, Lord, Slattery, Grainger, & Symonds, 2012) . Understanding distress and providing supportive care early in the treatment trajectory will help to improve gynecologic cancer survivors' psychosocial well-being.
Distress screening instruments should be reliable and patient-friendly and should focus on QOL. The NCCN Distress Thermometer (DT) has been praised for its ease of integration into clinical practice (Juarez, Hurria, Uman, & Ferrell, 2013; Ploos van Amstel et al., 2013) . Use of a generic QOL tool with consideration of disease-and/or treatment-related side effects is most valuable. A multidisciplinary management approach is essential for the psychosocial assessment of cancer survivors (Hanssens et al., 2011 BACKGROUND: A gynecologic cancer diagnosis and subsequent treatment may cause significant morbidity, leading to increased distress levels and poorer quality of life (QOL) for survivors. Clinicians have explored opportunities to integrate comprehensive distress management protocols into clinical settings using existing supportive care resources.
OBJECTIVES:
The aims were to improve multidisciplinary management of distress using a clinical pathway for gynecologic cancer survivors and to improve patient satisfaction with distress management.
METHODS: This study is phase II of a quality improvement initiative to assess distress using the National Comprehensive Cancer Network Distress Thermometer and Patient Related Outcome Measures Information Systems QOL tool and to evaluate the use of a clinical pathway to identify and link gynecologic cancer survivors to multidisciplinary supportive care resources. The data were compared to results from phase I of this study with data triangulation that included medical record audits.
FINDINGS: Thirty-five percent of survivors reported distress scores of 5 or greater. The use of a clinical pathway model for universal distress screening increased referrals to multidisciplinary service teams from 19 to 34, with a 32% increase in social work referrals. Patients appreciated the comprehensive approach the healthcare team used to treat cancer and help improve QOL.
DISTRESS SCREENING
members of the healthcare team, including oncologists, nurses, social workers, nutritionists, mental health providers, physical therapists, and chaplains, will aid in a program's success.
This project followed the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) theoretical framework (Glasgow, Vogt, & Boles, 1999) . Each component of the framework allows for thorough evaluation of the target population(s) and seeks to find which evidence-based interventions have been proven effective and how the program will be implemented in the practice setting. Although the RE-AIM framework is used mostly within the public health and community sectors, its various areas of application makes it easily adaptive to almost any environment and has been effectively used with patients with cancer for disease promotion. This framework uses an integrative and collaborative approach to project planning, a central construct identified in the literature review of distress screening practices.
Adjusting to the new normal following cancer treatment is challenging. The innovation presented in this article is phase II of a quality improvement initiative to pilot a universal distress screening protocol. Prior to pilot implementation, distress screening did not take place within the ambulatory care center. Phase I used focus groups to identify unmet needs and patient satisfaction with distress assessment and management practices. Information learned from that phase helped to inform the intervention tested in phase II. The aims were to improve multidisciplinary management of distress for gynecologic cancer survivors and to improve patient satisfaction with distress management. Provider satisfaction and protocol feasibility were secondary outcomes. Healthcare providers are pressed to provide continued survivorship services with 
QUALITY-OF-LIFE SURVEY

PATIENT AND HEALTHCARE PROVIDER SATISFACTION SURVEYS
PATIENT SATISFACTION SURVEY
Please respond to each item by marking one box below per row. Do not complete until after the doctor visit. This new approach is an appropriate way to assess and manage distress. I feel satisfied with providing solutions for patients' distress needs. This process had a positive effect on my clinic.
Suggestions for improvement
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Procedures
Baseline data were obtained from electronic health records (EHRs) using a convenience sample of patients who presented for surveillance clinic visits from October to November 2015. Documentation of distress and the frequency and type of multidisciplinary referrals were noted. The patient satisfaction survey results from phase I were also included in the data analysis for comparison.
One week prior to implementation, the project team leader conducted three 15-minute educational briefing sessions during routine work hours. The purposes of the pilot intervention were to increase awareness of distress, initiate clinical pathway management, institute application of distress screening tools, and create role-specific duties. Same-day educational briefing sessions were provided to rotating residents and fellows during the pilot. The distress screening tools included the NCCN DT and Problem List, which can be found online at http://bit.ly/1SMfIew, and a quality-of-life survey (see Figure 1 ).
Gynecologic cancer survivors were prescreened by the research team following review of the clinic schedule. At the beginning of the clinic visit, a list was provided to support staff. Patients in the waiting room were asked to complete the distress screening tools at check-in. Screening results were reviewed by the medical provider and triaged per the clinical pathway. Social workers were notified of patients with distress scores of 8 or greater for same-day contact via telephone or face-to-face meeting based on patient preference. The distress scores and management plan were documented, and distress screening tools were scanned into the EHR.
Instruments
The NCCN DT and National Institutes of Health Patient-Reported Outcomes Measurement Information System (PROMIS) tools were used for evaluating distress screening in the innovation group. The NCCN DT is an 11-point scale ranging from 0-10, with 0 indicating no distress and 10 indicating extreme distress. A score of 4 or higher suggests clinically significant distress (NCCN, 2016) . Sensitivity and specificity analysis for NCCN DT cutoff of 4 or greater (0.79) and 5 or greater (0.7) when compared to the Hospital Anxiety and Depression Scale (HADS) and Brief Symptom Index for general caseness (the degree to which the accepted diagnostic criteria for a condition are applicable to a patient) and severe psychological distress, respectively (Grassi et al., 2013) . In another study, a cutoff of 5 or greater proved 0.85 sensitivity when compared with the HADS (Tuinman, Gazendam-Donofrio, & Hoekstra-Weebers, 2008) .
Further review of the literature revealed the following correlated scores for distress: mild (4-5), moderate (6-7), and severe (8 or higher) (Mitchell, Hussain, Grainger, & Symonds, 2011) . Given the limited institutional social worker resources and the information from the literature, a clinical pathway was developed for a distress screening management process. If a patient had mild distress (less than 5), the clinician would review sources of Continued on the next page distress, provide patients with a list of hospital and community resources, and offer referrals as needed. If the patient had moderate distress, the clinician would perform the duties listed in the mild distress category and order referrals based on problem need. If the patient had severe distress, the clinician would perform actions under mild and moderate categories, as well as offer a same-day consultation with a social worker. Distress scores, associated problems, and plans of care were documented in the EHR for each patient The PROMIS-General Health (PROMIS-G) is a 10-item instrument with a maximum score of 50 points, which can be scored into separate Global Physical Health (PROMIS-GPH) and Global Mental Health (PROMIS-GMH) components. A raw score in each physical and mental category (maximum of 20 for each component) was converted to a t score for analysis. Higher scores represented healthier populations and improved QOL (PROMIS, 2016) .
To evaluate satisfaction with distress assessment and management during their visit, patients were asked to complete a five-point Likert-type survey developed by the study team at the end of the visit (see Figure 2) . Medical providers completed satisfaction surveys at the conclusion of the pilot program to assess pilot feasibility.
Data Analysis
Descriptive analysis, frequency, independent t tests, chi-square tests, and multiple logistic regression statistics were used to analyze data obtained from the chart review, pilot participants, and provider satisfaction survey results. Clinical pathway process flow was analyzed by post-clinic chart reviews to determine if the documented distress score correlated with the suggested clinical pathway management plan. Some participants appeared in both retrospective chart audits and in the prospective innovation study. In efforts to preserve an independent sample, those patients were excluded from the prospective data. SPSS ® , version 23.0, was used for data analysis.
Findings
Patient Characteristics
The innovation cohort included 65 gynecologic cancer survivors. The historic chart analysis included 73 survivors; 18 patients were removed from the prospective data (see Table 1 ). The mean age of participants in the chart audit cohort was 55.6 years (SD = 14.4, range = 18-81). The mean age of participants in the pilot phase cohort was 55.9 years (SD = 15.8, range = 20-89). Sixty-five percent of the women were Caucasian, married, and employed with private insurance. The types of cancer diagnoses were similar between groups, with ovarian and endometrial being the most prevalent.
Comparison Between Instruments
The mean distress score was 3.19 (SD = 3.05), with 24 survivors reporting distress scores of 5 or greater. The number of participants with contributing problems were as follows: practical (n = 22), family (n = 10), emotional (n = 36), and physical (n = 50). No participants reported spiritual problems.
The mean PROMIS-GMH raw score was 14.3 (t score = 48.3), and the mean PROMIS-GPH raw score was 14.91 (t score = 47.7). The mean overall PROMIS-G score was 36.05 (SD = 7.72). The relationship between NCCN DT and overall PROMIS-G scores was investigated using Spearman's product-moment correlation coefficient. There was a strong, negative correlation between the two variables (p < 0.001), with high levels of distress associated with lower levels of overall QOL.
Evaluation of Distress and Referrals
The total number of referrals from the chart audit versus the innovation group was 19 and 34, respectively. Types of referrals included social workers, palliative care, physical therapy, the Kelly Gynecologic Oncology Survivorship Center, and a weight management center. Pearson's chi-square tests were conducted for each referral type; no social worker referrals were observed in the chart audit group, compared to 21 referrals in the innovation group (p < 0.001). Of the remaining referral types, no significant differences were noted for the remaining referral types (see Table  2 ). Multiple logistic regression analysis (see Table 3 ) was used to determine if age, marital status, employment status, multiple adjuvant therapies (2 or more), or total number of referrals were associated with distress scores of 5 or greater. Two variables were associated with distress: multiple adjuvant therapies (odds ratio Fifty survivors reported mild distress, five reported moderate distress, and nine reported severe distress. Twenty-two referrals were recommended for survivors with mild and moderate distress; five patients declined. Of the 12 referrals recommended for survivors with severe distress, three patients received same-day referrals with social workers. The remaining patients declined same-day consultations because two were already undergoing psychosocial care, two reported that they improved to "mild" distress after reviewing test results with the healthcare provider, and two declined without reason. One patient was not presented the opportunity for a same-day consultation; however, a social worker made contact with that patient within 48 hours. Sixty-seven percent of patients who were recommended a referral at the time of their appointment accepted the services. Overall, the pathway was followed correctly 98% of the time. The NCCN DT score was documented in the EHR 92% of the time.
Patient and Provider Satisfaction
The pilot satisfaction survey was completed by 38 of 65 survivors, yielding a 58% response rate. Thirty survivors stated that their distress needs were assessed and managed to their satisfaction, with 14 receiving a referral at the time of their visit. The NCCN DT demonstrated ease of use among 34 respondents, with 5 stating that the survey was time-consuming. Twenty-eight respondents noted overall satisfaction with distress management from the healthcare team. A response of strongly agree or agree was deemed satisfactory.
Phase II patient satisfaction survey results were compared with phase I results using independent samples t test. Question items of "my distress needs were assessed and managed to my satisfaction" and "overall satisfaction with the healthcare team" achieved significant results (p < 0.0001 and p = 0.008, respectively). No additional significant differences were noted among the question items. Results are displayed in Figure 3 .
Nine of 12 staff members who participated in the innovation pilot completed the provider satisfaction surveys, yielding a 75% response rate. One respondent stated that the screening program caused a delay or disruption with clinic practices. All of the respondents agreed that the new approach was an appropriate way to assess and manage distress. Seven participants felt satisfied with managing patient distress needs, and eight stated the screening program had a positive effect in the clinic. Determining the best timing for screening (e.g., at the beginning versus end of a visit) and how to support patients with high distress unassociated with cancer (e.g., other comorbidities) were listed as suggestions for improvement.
Feasibility of Protocol Implementation
The clinical pathway was specifically developed to assist survivors with same-day referrals for severe distress. Three hours of DISTRESS SCREENING dedicated social worker time were provided during the pilot period for same-day contact via face-to-face or telephone consultation.
Challenges to the availability of social workers during the pilot phase were related to part-time employment status, unanticipated vacation or staff illness, or co-managing other departmental responsibilities. Securing clinical work space for patient interviews and assessments also posed a challenge initially.
Discussion
This study adds to the limited body of literature on distress management and its impact on QOL for gynecologic cancer survivors. The incidence of distress scores of 5 or greater (35%) in this cohort was slightly below the national average of 40%-50% reported in the literature for all cancer types (Mitchell et al., 2012; Vitek et al., 2007) ; however, it is comparable to that of breast cancer survivors (33%) (Hegel et al., 2008 ). An inverse relationship was found between distress and QOL, with increased levels of distress resulting in poorer QOL scores, which also correlates with findings from the literature (Chachaj et al., 2010; Foster, Wright, Hill, Hopkinson, & Roffe, 2009; Frumovitz et al., 2005; Hodgkinson, Butow, Fuchs, et al., 2007; Hodgkinson, Butow, Hunt, et al., 2007; Leak, Hu, & King, 2008; Menhert & Koch, 2008; Morrow et al., 2014; Ploos van Amstel et al., 2013; Roland, Rodriguez, Patterson, & Trivers, 2013; Taylor et al., 2012) . Distress scores of 5 or greater were less likely to be associated with increased referrals and multiple adjuvant treatments. Ellis et al. (2009) found that increased referrals to supportive services were associated with younger age, single marital status, and low socioeconomic standing. The demographic makeup of the innovation cohort in this study likely contributed to the outcome. Determining the best way to integrate comprehensive psychosocial assessments within cancer care is imperative, particularly when using existing supportive resources. Similar quality improvement studies in the literature showcased success with protocol and practice guideline development (Hammelef et al., 2014; Hammonds, 2012) . The study team incorporated multiple management techniques for psychosocial support in the innovation cohort to meet the cultural needs of the institution. The interventions included face-to-face or telephone interviews, a tactic supported by the literature (Matulonis et al., 2008; Taylor et al., 2012; Wenzel et al., 2005) . This allowed patients to choose consultation preference and increased flexibility for the social workers to optimize their schedules.
The authors noted several clinical findings regarding program implementation that warrant discussion. First, compared to the chart audit group, the innovation cohort had a 32% increase of social worker referrals. This could be, in part, because of the screening pilot itself or because of the collaboration and availability of the social workers to be available for same-day consultations. Second, although gynecologic cancer survivors were overall satisfied with the screening process, the providers reported a few concerns. Two patients were noted to have severe levels of distress at the beginning of the visit. However, after discussing surveillance imaging and laboratory results, their distress levels were reportedly mild. This raised questions regarding the timing of screening (i.e., whether it should be performed at the beginning, middle, or end of the visit). Consideration of repeating screening following a consultation with the physician or having patients complete a referral form, in addition to the screening tool, may help to address this issue. Providers also voiced concerns with how best to support patients with high distress levels unassociated with cancer. Many patients with cancer have multiple comorbidities and side effects from these conditions that contribute to distress. The NCCN DT instructions are generic and do not specifically state to indicate distress level based on cancer-and treatment-related side effects, but perhaps this should be included to tailor the consultation and management process.
Limitations
This feasibility pilot was performed at a single cancer center with a small sample size and during a short period of time; therefore, results may not be generalizable to other cancer settings or groups. The authors did not specify the number of months to years from end of treatment for patients, which could affect the outcome and generalizability of results because survivors may 
Conclusion
The clinical pathway developed successfully triaged distress needs for gynecologic cancer survivors. Patients and providers praised the screening program and valued its importance in providing comprehensive cancer care. Having access to multidisciplinary services for supportive care, particularly social workers, can be challenging. Further research is needed to determine the most appropriate time to implement distress screening and the repeat distress screening intervals along the gynecologic cancer trajectory. Focusing on cancer-related distress can help improve patient and program outcomes. The authors take full responsibility for this content and did not receive honoraria or disclose any relevant financial relationships. The article has been reviewed by independent peer reviewers to ensure that it is objective and free from bias. 
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